Company intelligence / Profile preview

PranaQ

New York City, New York, United Statespranaq.com ↗

Ownership: Private
Development stage: Other

Overview

PranaQ has received FDA 510(k) clearance for its TipTraQ wearable, which provides clinical-grade, AI-powered home testing and monitoring of sleep apnea and respiratory disorders. The device enables multi-night testing with remote data transfer, improving patient compliance and access to diagnosis.

Therapeutic areas: Pulmonology
Modalities: DeviceAI-based biomedical signal-processing algorithm
Industry: Physiological Monitoring

Partnerships

NAVER D2SF

Beyond the preview

Go deeper on PranaQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PranaQ.

Explore the full profile